|
|
Bone Disease Treatment Market Research Reports
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Bone Disease Treatment Market, including, but not limited to latest trend on thrapeutic of: Osteoporosis; Osteoarthritis; Rheumatoid Arthritis; Myeloma; Osteoarthropathy; Osteochondritis; OAP; OA; Bone Substitutes; Osteoanagenesis.
We offer market research, industry forecasts, and business analysis in the Bone Disease Treatment Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Osteoporosis Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from 2004 to $9.6 billion in 2008 driven by strong per ... |
| Multiple Myeloma Therapeutics |
|
| Table of Contents Published: 2009/04 Published by: Global Industry Analysts, Inc. |
| This report analyzes the US market for Multiple Myeloma Therapeutics in Millions of US$. TThe market for multiple myeloma therapeutics is analyzed by the following Drugs: Thalomid, Revlimid, Velcade, and Others. The market for multiple myeloma therapeutic ... |
| Chinese Markets for Osteoporosis Drugs |
|
| Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co. |
| China' s demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, s ... |
| European Bone Growth and Spinal Fusion Stimulators Markets |
|
| Table of Contents Published: 2008/10 Published by: Frost & Sullivan |
| This research service examines the European bone growth and spinal fusion stimulator markets in terms of the challenges faced by market participants, drivers, and restraints in the industry, the competitive structure in the major markets, the revenue fore ... |
| U.S. Osteoporosis Market |
|
| Table of Contents Published: 2008/06 Published by: Frost & Sullivan |
| This research service covers the U.S. osteoporosis market from 2004-2014. Included are disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product cl ... |
| Musculo-Skeletal-Disorders Osteoporosis |
|
| Table of Contents Published: 2008/03 Published by: Life Science Analytics |
| This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area. ... |
| Musculo-Skeletal-Disorders Muscle Pain |
|
| Table of Contents Published: 2008/03 Published by: Life Science Analytics |
| This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area. ... |
| Musculo-Skeletal-Disorders Gout |
|
| Table of Contents Published: 2008/03 Published by: Life Science Analytics |
| This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area. ... |
| Osteoporosis Therapeutics |
|
| Table of Contents Published: 2008/03 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Osteoporosis Therapeutics in Millions of US$. The specific product segments analyzed are Bisphosphonates, ERT Drugs, SERMs, and Calcitonins. The report provides separate comprehensive analytics for the US, Ja ... |
| Brands & Strategies: Osteoporosis |
|
| Table of Contents Published: 2007/10 Published by: Decision Resources, Inc. |
| The osteoporosis market has traditionally been dominated by the bisphosphonate drug class, championed by Merck' s once-weekly Fosamax (alendronate) and Procter & Gamble[P&G]/Sanofi-Aventis' Actonel (risedronate). This will change dramatically over the for ... |
| European Osteoarthritis Markets |
|
| Table of Contents Published: 2007/06 Published by: Frost & Sullivan |
| This Frost & Sullivan research service titled European Osteoarthritis Market provides an overview of current treatment options along with a complete analysis of key market drivers, restraints and trends prevailing in the market. ... |
| U.S. Spinal Surgery Markets |
|
| Table of Contents Published: 2007/05 Published by: Frost & Sullivan |
| This Frost & Sullivan research service titled U.S. Spinal Surgery Market provides overview of the spinal surgery industry and segment-wise revenues and market shares, along with a complete analysis of major market drivers, restraints and trends impacting ... |
| Advances in DEXA |
|
| Table of Contents Published: 2007/03 Published by: Technical Insights, Inc. |
| This study discusses and analyzes the advancements made in DEXA and its applications in diagnosis and treatment of diseases such as osteoporosis. ... |
| U.S. Multiple Myeloma Market |
|
| Table of Contents Published: 2007/03 Published by: Frost & Sullivan |
| The U.S. Multiple Myeloma Market is a rapidly progressing field that is set to generate over $3 billion in revenue in the coming years. ... |
| New Drug Futures: Musculoskeletal |
|
| Table of Contents Published: 2006/05 Published by: Espicom Business Intelligence |
| This chapter of New Drug Futures evaluates, compares and contrasts the prospects for the compounds that will revolutionise the pharmaceutical industry over the next 5 years and beyond in the musculoskeletal sector. ... |
| Juvenile Arthritis - A Niche In The Market |
|
| Table of Contents Published: 2005/12 Published by: Datamonitor |
| Juvenile arthritis is the next indication due for approval for blockbuster biologic therapies Remicade (infliximab) and Humira (adalimumab). Pediatric rheumatology is a growing specialty that offers high unmet need in terms of effective well-tested treatm ... |
| Orthopedic Drugs, Implants and Devices |
|
| Table of Contents Published: 2004/10 Published by: BCC Research |
| The total orthopaedic drug, implant and device market is expected to reach $44 billion by end of 2004. Rising at an average annual growth rate (AAGR) of 11%, the market is expected to reach $74.1 billion by 2009. ... |
| U.S. Arthritis Therapies Markets |
|
| Table of Contents Published: 2004/05 Published by: Frost & Sullivan |
| This Frost & Sullivan research service analyzes the key drivers and challenges influencing the U.S. arthritis therapies market. Product and pricing trends coupled with patient and revenue forecasts enable participants to formulate a structured marketing p ... |
|
| Orthopaedics Business News |
|
| Issues / Year: 12 Published by: Espicom Business Intelligence |
| Orthopaedics Business is a new business information service designed specifically to keep busy executives in touch with the companies, products and market for all types of orthopaedic device equipment. ... |
|
|
|
View Cart
